Angeli Moeller

Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA.

Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA.

Metamarkets Group, Inc. provides price data and predictive analytics to publishers and web companies. It offers inventory discovery, marketplace monitor, and bid monitor. The company was founded by David Soloff and Michael E. Driscoll in 2010 and is headquartered in San Francisco, CA.

doubleTwist Corp. provides software solutions that connect consumers with various types of media. It offers AirSync, which enables its users to sync iTunes playlists, photos, and videos to their Android phones using home Wi-Fi network. The company was founded by Monique Farantzos and Jon Lech Johansen in March 2007 and is headquartered in Austin, TX.

Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.

Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022.

Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA.

Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware.

GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London.

Tiber Capital Group is a real estate investment firm that specializes in the acquisition and management of single-family homes. The private company is based in Capitol Heights, MD and was founded by Jonathan Seigel and Simon Frost. Tiber Capital Group is committed to being a world-class investment firm that identifies value that others may overlook, while delivering superior results through rigorous financial and risk discipline. Simon Frost has been the CEO since incorporation. The American company's management team has acquired and managed over 18,750 single-family homes and renovated over 28,000 homes and apartments.

Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling.

LifeTech Development Partners LP (LifeTech Development) is a venture capital subsidiary of LifeTech Research, Inc. founded in 2008 by Joel Braunstein. The firm is headquartered in Baltimore, Maryland.

C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation.

The Canadian Cancer Society operates as a non-profit organization that provides cancer charity services. It offers support and services and programs for the prevention and screening of cancer. The company was founded in 1938 and is headquartered in Toronto, Canada.

The Global Alliance for Genomics & Health is an organization that creates standards and tools for the genomics and health community. The non-profit company is based in Toronto, Canada. All of their products go through an approval process before being adopted. The Canadian company offers implementations of their products and showcase how they solve real problems for organizations worldwide. The goal of the organization is to unlock the power of genomic data to benefit human health.

Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.

Key Property Solutions LLC purchases, resells, manages, and rents single-family homes and investment properties. It offers standard patch and fix of small items, paint, installation of toilet seats, shower rods and liners, replacement of broken and missing blinds, deep car pet cleaning, pest control inspection and general spray, ceiling fans, bathroom and kitchen fixtures and fencing repairs and water heater replacement. The company was founded by Jeff W. Brock in 2001 and is headquartered in Marietta, GA.

CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.